1. Home
  2. |Insights
  3. |Deal Note: Crowell & Moring Represents Verisk Analytics, Inc. in Healix Risk Rating Acquisition

Deal Note: Crowell & Moring Represents Verisk Analytics, Inc. in Healix Risk Rating Acquisition

Firm News | 1 min read | 02.16.17

London, February 16, 2017: Crowell & Moring represented Verisk Analytics, Inc., a leading data analytics provider, on its acquisition of Healix Risk Rating, a leader in automated medical risk assessment for the travel insurance industry. Healix Risk Rating, a subsidiary of Healix International Holdings Limited, will become part of ISO, a Verisk Analytics business and a pre-eminent source of information about property/casualty insurance risk for more than 45 years. The transaction will further expand Verisk Analytics’ risk assessment offerings for the global insurance industry.

The Crowell & Moring team representing Verisk Analytics Inc. was led by London corporate partner Simon Evers and London associate Amar Singh Mann.

Insights

Firm News | 1 min read | 11.08.24

Crowell & Moring Represents Marshall Wace as Lead Investor in Inquis Medical’s $40 Million Series B Financing

San Francisco – November 8, 2024:  Marshall Wace led Inquis Medical’s oversubscribed $40 million Series B round, along with participation from existing investors, including ShangBay Capital, Yu Star, EnPointe Ventures, and Pierre Lamond.